V. M. MANNING & CO., INC.’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.39K Buy
+22,200
New +$1.39K ﹤0.01% 47